{{medical}}
{{drugbox
| verifiedrevid = 292083513
| IUPAC_name = 7-[2-[(4-羟基-6-甲基吡啶-3-羰基)-氨基]-2-(4-羟基苯基)-乙酰氨基]-3-(1-甲基-1H-四唑-5-硫代甲基)-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸<br />(6''R'')-7-{[(2''R'')-2-(4-hydroxyphenyl)-2-[(6-methyl-<br>4-oxo-1''H''-pyridine-3-carbonyl)amino]acetyl]amino}-<br>3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-<br>5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefpiramide.svg
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 70797-11-4
| ATC_prefix = J01
| ATC_suffix = DD11
| ATC_supplemental =  
| PubChem = 636405
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00430
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 552192
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = P936YA152N
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03428
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 59213
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201204
| C = 25 | H = 24 | N = 8 | O = 7 | S = 2
| molecular_weight = 612.64 g/mol
| bioavailability = 
| protein_bound = 93%至99.3%
| metabolism = 
| elimination_half-life = 4.44 hours
| excretion = [[Kidney|Renal]] and fecal
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status = 
| routes_of_administration = [[静脉注射|静脉注射]]、[[肌肉注射|肌肉注射]]
}}

'''头孢匹胺'''也称为“'''头孢吡胺'''”“'''头孢吡四唑'''”或“'''甲吡唑头孢菌素'''”，是一种[[头孢菌素#第三代|第三代头孢菌素]]。此[[抗生素|抗生素]]对[[革兰氏阳性菌|革兰氏阳性菌]]（包括[[葡萄球菌|葡萄球菌]]、[[链球菌|链球菌]]、[[消化球菌|消化球菌]]等）具有很强的抗菌作用，对[[绿脓杆菌|绿脓杆菌]]等[[革兰氏阴性杆菌|革兰氏阴性杆菌]]也有较强的作用。头孢匹胺对[[β－内酰胺酶|β－内酰胺酶]]稳定。

==外部链接==
* {{cite journal | author = Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M | title = In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China. | journal = J Infect Chemother | volume = 6 | issue = 2 | pages = 81–5 | year = 2000 | pmid = 11810540 | doi = 10.1007/PL00012156}}
* {{cite journal | author = Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G | title = [Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery] | journal = Antibiot Khimioter | volume = 40 | issue = 9 | pages = 30–4 | year = 1995 | pmid = 8651827}}
* {{cite journal | author = Sampi K, Hattori M | title = [Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study] | journal = Gan To Kagaku Ryoho | volume = 19 | issue = 9 | pages = 1315–20 | year = 1992 | pmid = 1503486}}

{{CephalosporinAntiBiotics}}

[[Category:头孢菌素|Category:头孢菌素]]
[[Category:四唑|Category:四唑]]
[[Category:4-吡啶|Category:4-吡啶]]

{{antibiotic-stub}}